Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease
NCT07474220 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2026-03-17
Summary
This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.
Conditions
Sponsors & Collaborators
-
Fu Jen Catholic University
lead OTHER
Principal Investigators
-
Ke-Yun Chao, PhD · Fu Jen Catholic University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
NCT07012759 ·Status: RECRUITING
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
S9925: Collecting and Storing Samples From Patients With Lung Cancer
NCT00920010 ·Status: COMPLETED
-
The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer
NCT04018183 ·Status: COMPLETED
-
A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy
NCT03130192 ·Status: UNKNOWN
-
Circulating EV Long RNA Profiles in SCLC
NCT05191849 ·Status: UNKNOWN ·Phase: NA
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
NCT00257179 ·Status: UNKNOWN
-
Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung Disease
NCT02779049 ·Status: COMPLETED
-
Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer
NCT05770063 ·Status: UNKNOWN ·Phase: NA
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
NCT06801977 ·Status: RECRUITING
-
Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma
NCT03641105 ·Status: UNKNOWN
-
Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung Cancer
NCT04260295 ·Status: UNKNOWN
-
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
NCT04137718 ·Status: UNKNOWN
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
NCT06518655 ·Status: RECRUITING
-
Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue
NCT01058811 ·Status: UNKNOWN
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 ·Status: COMPLETED
-
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
NCT00797238 ·Status: UNKNOWN
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Prospective Observational Study on ES-SCLC
NCT07173946 ·Status: NOT_YET_RECRUITING
-
The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism
NCT01280448 ·Status: UNKNOWN